É um termo genérico para um grupo de doenças de pele genéticas raras, caracterizadas por placas bem delimitadas de pele avermelhada, seca e espessa. Geralmente, essas lesões se distribuem de forma simétrica no corpo e tendem a aumentar lentamente de tamanho e a evoluir com o tempo.
Introdução
O que você precisa saber de cara
É um termo genérico para um grupo de doenças de pele genéticas raras, caracterizadas por placas bem delimitadas de pele avermelhada, seca e espessa. Geralmente, essas lesões se distribuem de forma simétrica no corpo e tendem a aumentar lentamente de tamanho e a evoluir com o tempo.
Tem tratamento?
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 46 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 132 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
13 genes identificados com associação a esta condição.
Acts as a scaffolding protein that can activate the inflammatory transcription factor NF-kappa-B and p38/JNK MAP kinase signaling pathways. Forms a signaling complex with BCL10 and MALT1, and activates MALT1 proteolytic activity and inflammatory gene expression. MALT1 is indispensable for CARD14-induced activation of NF-kappa-B and p38/JNK MAP kinases (PubMed:11278692, PubMed:21302310, PubMed:27071417, PubMed:27113748). May play a role in signaling mediated by TRAF2, TRAF3 and TRAF6 and protects
Cytoplasm
Psoriasis 2
A common, chronic inflammatory disease of the skin with multifactorial etiology. It is characterized by red, scaly plaques usually found on the scalp, elbows and knees. These lesions are caused by abnormal keratinocyte proliferation and infiltration of inflammatory cells into the dermis and epidermis.
Major keratinocyte cell envelope protein
CytoplasmNucleus, nucleoplasm
Vohwinkel syndrome with ichthyosis
A variant form of Vohwinkel syndrome without hearing loss and associated with ichthyosiform dermatosis. Clinical features include palmoplantar keratoderma, pseudoainhum and ichthyosis. Compact hyperkeratosis with round retained nuclei and hypergranulosis is observed on skin biopsies.
Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes (PubMed:31630791). The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules
Golgi apparatusCytoplasmic vesicle, clathrin-coated vesicle membrane
Keratitis-ichthyosis-deafness syndrome, autosomal recessive
An autosomal recessive form of keratitis-ichthyosis-deafness syndrome, a disease characterized by the association of hyperkeratotic skin lesions with vascularizing keratitis and profound sensorineural hearing loss. KIDAR patients manifest ichthyosis, failure to thrive and developmental delay in childhood, thrombocytopenia, photophobia, and progressive hearing loss. Low plasma copper and ceruloplasmin levels have been reported in some patients.
Structural component of gap junctions (By similarity). Gap junctions are dodecameric channels that connect the cytoplasm of adjoining cells. They are formed by the docking of two hexameric hemichannels, one from each cell membrane (By similarity). Small molecules and ions diffuse from one cell to a neighboring cell via the central pore (By similarity)
Cell membraneCell junction, gap junction
Erythrokeratodermia variabilis et progressiva 2
A form of erythrokeratodermia variabilis et progressiva, a genodermatosis characterized by the coexistence of two independent skin lesions: transient erythema and hyperkeratosis that is usually localized but occasionally occurs in its generalized form. Clinical presentation varies significantly within a family and from one family to another. Palmoplantar keratoderma is present in around 50% of cases.
Erythrokeratodermia variabilis et progressiva 5
A form of erythrokeratodermia variabilis et progressiva, a genodermatosis characterized by the coexistence of two independent skin lesions: transient erythema and hyperkeratosis that is usually localized but occasionally occurs in its generalized form. Clinical presentation varies significantly within a family and from one family to another. Palmoplantar keratoderma is present in around 50% of cases. EKVP5 inheritance is autosomal recessive.
One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell
Cell membraneCell junction, gap junction
Erythrokeratodermia variabilis et progressiva 1
A form of erythrokeratodermia variabilis et progressiva, a genodermatosis characterized by the coexistence of two independent skin lesions: transient erythema and hyperkeratosis that is usually localized but occasionally occurs in its generalized form. Clinical presentation varies significantly within a family and from one family to another. Palmoplantar keratoderma is present in around 50% of cases.
A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (PubMed:25733715). Critical for cell-cell adhesion in early stage blastocysts and progression through proamniotic cavity formation (By similarity). Not required for preimplantation morphogenic process in blastocysts (By similarity). Required for keratin filament anchoring at the desmosome junction and subsequent organization of the keratin intermediate filament network within the cytoplas
Cell projection, axonCell junction, desmosomeCell membraneCytoplasmNucleus
Keratoderma, palmoplantar, striate 2
A dermatological disorder characterized by thickening of the skin on the palms (linear pattern) and the soles (island-like pattern) and flexor aspect of the fingers. Abnormalities of the nails, the teeth and the hair are rarely present.
Structural component of the gap junction, a specialized intercellular structure consisting of a cluster of closely packed pairs of transmembrane channels, the connexons, that allow passage of small molecules and electrical signals between neighboring cells (By similarity). Forms homotypic and heterotypic channels gated by transjunctional voltage (By similarity). May play a critical role in the physiology of hearing by participating in the recycling of potassium to the cochlear endolymph (Probabl
Cell membraneCell junction, gap junctionEndoplasmic reticulumCell junction
Oculodentodigital dysplasia
A disease characterized by a typical facial appearance and variable involvement of the eyes, dentition, and fingers. Characteristic facial features include a narrow, pinched nose with hypoplastic alae nasi, prominent columella and thin anteverted nares together with a narrow nasal bridge, and prominent epicanthic folds giving the impression of hypertelorism. The teeth are usually small and carious. Typical eye findings include microphthalmia and microcornea. The characteristic digital malformation is complete syndactyly of the fourth and fifth fingers (syndactyly type III) but the third finger may be involved and associated camptodactyly is a common finding. Cardiac abnormalities are observed in rare instances.
Calcium-activated selective cation channel that mediates membrane depolarization (PubMed:12015988, PubMed:12842017, PubMed:29211723, PubMed:30528822). While it is activated by increase in intracellular Ca(2+), it is impermeable to it (PubMed:12015988). Mediates transport of monovalent cations (Na(+) > K(+) > Cs(+) > Li(+)), leading to depolarize the membrane (PubMed:12015988). It thereby plays a central role in cadiomyocytes, neurons from entorhinal cortex, dorsal root and vomeronasal neurons, e
Cell membraneEndoplasmic reticulumGolgi apparatus
Progressive familial heart block 1B
A cardiac bundle branch disorder characterized by progressive alteration of cardiac conduction through the His-Purkinje system, with a pattern of a right bundle-branch block and/or left anterior hemiblock occurring individually or together. It leads to complete atrio-ventricular block causing syncope and sudden death.
Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules
Golgi apparatusCytoplasmic vesicle membraneMembrane, clathrin-coated pit
MEDNIK syndrome
A disorder characterized by erythematous skin lesions and hyperkeratosis, severe psychomotor retardation, peripheral neuropathy, sensorineural hearing loss, together with elevated very-long-chain fatty acids and severe congenital diarrhea.
Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle. Condensing enzyme that catalyzes the synthesis of very long chain saturated (VLC-SFA) and polyunsaturated (PUFA) fatty acids that are involved in multiple biological processes as precursors of membrane lipids and
Endoplasmic reticulum membrane
Stargardt disease 3
A form of Stargardt disease, a common hereditary macular degeneration characterized by decreased central vision, atrophy of the macula and underlying retinal pigment epithelium, and frequent presence of prominent flecks in the posterior pole of the retina. STGD3 is an autosomal dominant form with onset most commonly in the second decade of life.
Component of intercellular desmosome junctions (By similarity). Plays a role in stratified epithelial integrity and cell-cell adhesion by promoting desmosome assembly (By similarity). Thereby plays a role in barrier function of the skin against infection (By similarity). Plays a role in mammary epithelial tissue homeostasis and remodeling during and after pregnancy, potentially via its involvement in desmosome cell-cell junctions (By similarity). Required for tooth enamel development via facilit
Cell junction, desmosomeCell membraneCytoplasm
Erythrokeratodermia variabilis et progressiva 7
A form of erythrokeratodermia variabilis et progressiva, a genodermatosis characterized by the coexistence of two independent skin lesions: transient erythema and hyperkeratosis that is usually localized but occasionally occurs in its generalized form. Clinical presentation varies significantly within a family and from one family to another. Palmoplantar keratoderma is present in around 50% of cases. EKVP7 is an autosomal recessive form characterized by palmoplantar keratoderma that extends to the dorsal surface of the hands and feet, as well as erythematous annular skin lesions. Pruritus, woolly hair, and dystrophic nails may also be present.
Catalyzes the reduction of 3'-oxosphinganine (3-ketodihydrosphingosine/KDS) to sphinganine (dihydrosphingosine/DHS), the second step of de novo sphingolipid biosynthesis
Endoplasmic reticulum membrane
Medicamentos e terapias
Mecanismo: Interleukin 17A inhibitor
Mecanismo: Interleukin-23 inhibitor
Mecanismo: Tyrosine-protein kinase TYK2 negative allosteric modulator
Mecanismo: Tyrosine-protein kinase TYK2 negative allosteric modulator
Mecanismo: Interleukin 17A inhibitor
Variantes genéticas (ClinVar)
152 variantes patogênicas registradas no ClinVar.
Classificação de variantes (ClinVar)
Distribuição de 25 variantes classificadas pelo ClinVar.
Vias biológicas (Reactome)
27 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Eritroceratodermia
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Pesquisa e ensaios clínicos
Nenhum ensaio clínico registrado para esta condição.
Publicações mais relevantes
Progressive symmetrical erythrokeratoderma associated with biallelic PNPLA1 variants.
A recurrent de novo damaging variant in EMP2 causes progressive symmetric erythrokeratoderma.
Genetic investigation in Mendelian skin disorders featuring generalized or localized skin scaling and redness, known as the ichthyoses, has revealed novel pathways relevant to epidermal integrity, barrier function, and desquamation. Here, we show that a recurrent de novo missense variant in EMP2 (epithelial membrane protein 2), which encodes a cell surface tetraspan protein in the growth-arrest specific 3 (GAS3)/peripheral myelin protein 22 (PMP22) family, is associated with a Mendelian skin disorder in the progressive symmetric erythrokeratoderma spectrum. The disorder features severely thickened, red, and scaly skin at sites of wound healing or repetitive movement including on the face, genitals, flexural areas, and the palms and soles. EMP2 has previously been shown to directly associate with focal adhesion kinase, which links cell junction forces to signaling pathways relevant to proliferation, migration, and wound healing. Using single-cell spatial transcriptomics in affected tissue, we found ectopic suprabasal activation of signaling pathways downstream of receptor tyrosine kinases including epidermal growth factor receptor (EGFR), which we confirmed with western blotting in affected cells, supporting a gain-of-function mechanism for mutant EMP2. Remarkably, treatment with erlotinib, an EGFR inhibitor, led to marked clinical improvement underscoring the key role of EMP2 in epidermal differentiation and proliferation.
Progressive Symmetric Erythrokeratoderma with Lesional Hypertrichosis: An Unusual Finding in a Rare Disease.
Progressive symmetric erythrokeratoderma (PSEK) is a rare genodermatosis with variable inheritance. It is characterized by symmetrical, erythematous, and hyperkeratotic plaques on the extremities. We report a case of a 16-year-old girl with PSEK of autosomal dominant inheritance associated with lesional hypertrichosis.
Topical Treatments for Rare Genetic Dermatological Diseases: A Narrative Review.
Rare diseases are conditions that affect up to 65 people per 100,000 individuals. They are also known as "orphan diseases", because they attract limited interest from researchers and pharmaceutical industries. Epidermolysis bullosa (EB), ichthyosis, Hailey-Hailey disease (HHD), Darier disease (DD), erythrokeratoderma, porokeratosis, inflammatory linear verrucous epidermal nevus (ILVEN) and piebaldism are examples of rare genetic skin diseases with few approved treatments. Topical treatments are the principal approach for rare dermatological diseases, and it can be useful to manage the symptoms or the patophysiology of these diseases. This study aimed to conduct a comprehensive review of the topical treatments of EB, ichthyosis, HHD, DD, erythrokeratodermias, porokeratosis, ILVEN, and piebaldism. The search was performed across the SciELO, MEDLINE®/PubMed®, Embase and Cochrane databases. This review identified porokeratosis, EB, and congenital ichthyosis as the rare genodermatoses with the highest number of reported studies and topical treatment options. In contrast, conditions such as piebaldism, erythrokeratodermia, and HHD have fewer reported topical interventions. For most rare genetic dermatological diseases, treatment aims to improve quality of life and control clinical signals and symptoms. Creams, gels, and ointments are frequently used as the main pharmaceutical approaches, and several pharmacological classes are employed, including keratolytics, retinoids, vitamin D analogs, topical corticosteroids, calcineurin inhibitors, and cytotoxic or antiproliferative agents. This review highlights the potential of off-label use of topical therapies as cost-effective alternatives in the treatment of rare genetic skin disorders. It also reinforces the critical role of compounded medicines in allowing for dose optimization, drug repurposing, and formulation adjustments, personalizing treatment to achieve improved therapeutic outcomes.
Erythrokeratodermia-Cardiomyopathy Syndrome: Expanding the DSP Mutational Spectrum Beyond Proline Substitutions.
Erythrokeratodermia cardiomyopathy (EKC) syndrome is a rare autosomal dominant disorder characterized by generalized erythrokeratoderma and progressive dilated cardiomyopathy, caused by pathogenic variants in the SR6 domain of desmoplakin (DSP). We report two cases of EKC with novel de novo missense DSP variants at phenylalanine position 590 (F590S and F590V), expanding the mutational spectrum beyond proline substitutions. Immunostaining demonstrated disrupted desmosomal protein localization. One patient showed significant clinical improvement with ustekinumab therapy. These findings underscore the need for early cardiac monitoring and support IL-12/23p40 inhibition as a potential therapeutic strategy in EKC.
Publicações recentes
Progressive symmetrical erythrokeratoderma associated with biallelic PNPLA1 variants.
Progressive Symmetric Erythrokeratoderma in an Adolescent With a Novel GJB3 Variant.
Progressive Symmetric Erythrokeratoderma with Lesional Hypertrichosis: An Unusual Finding in a Rare Disease.
Topical Treatments for Rare Genetic Dermatological Diseases: A Narrative Review.
Erythrokeratodermia-Cardiomyopathy Syndrome: Expanding the DSP Mutational Spectrum Beyond Proline Substitutions.
📚 EuropePMC93 artigos no totalmostrando 52
Progressive symmetrical erythrokeratoderma associated with biallelic PNPLA1 variants.
The British journal of dermatologyProgressive Symmetric Erythrokeratoderma in an Adolescent With a Novel GJB3 Variant.
International journal of dermatologyProgressive Symmetric Erythrokeratoderma with Lesional Hypertrichosis: An Unusual Finding in a Rare Disease.
International journal of trichologyTopical Treatments for Rare Genetic Dermatological Diseases: A Narrative Review.
Pharmaceuticals (Basel, Switzerland)Erythrokeratodermia-Cardiomyopathy Syndrome: Expanding the DSP Mutational Spectrum Beyond Proline Substitutions.
Pediatric dermatologyEffective Management of Familial Erythrokeratoderma Using Topical Calcipotriol.
CureusA recurrent de novo damaging variant in EMP2 causes progressive symmetric erythrokeratoderma.
Proceedings of the National Academy of Sciences of the United States of AmericaExpanding the SLURP1 disease spectrum: from Mal de Meleda to palmoplantar keratoderma/progressive symmetric erythrokeratoderma.
The British journal of dermatologyAutosomal dominant SLURP1 variants cause palmoplantar keratoderma and progressive symmetric erythrokeratoderma.
The British journal of dermatologyFour cases of Chanarin-Dorfman syndrome presenting with different types of erythrokeratoderma.
Pediatric dermatologyClinico-Epidemiologic Profile of Non-Syndromic Congenital Ichthyosis - A Retrospective Chart Review of 107 Patients.
Indian journal of dermatologyAlitretinoin as a Treatment Modality for Ichthyosis in Women of Childbearing Age: A Case Series and Review of the Literature.
Dermatology (Basel, Switzerland)Integration of Phenotype Term Prioritization and Gene Expression Analysis Reveals a Novel Variant in the PERP Gene Associated with Autosomal Recessive Erythrokeratoderma.
GenesOral Tofacitinib Therapy for the Effective Management of Netherton Syndrome.
CureusTwo New Families and a Literature Review of ELOVL4-Associated Spinocerebellar Ataxia Type 34.
Cerebellum (London, England)Variants in KLK11, affecting signal peptide cleavage of kallikrein-related peptidase 11, cause an autosomal-dominant cornification disorder.
The British journal of dermatologyVariable skin findings in two siblings with KDSR mutations manifesting in PERIOPTER syndrome.
Pediatric dermatologyErythrokeratoderma variabilis (EKV) - First Nepalese case documenting GJB3 mutation.
Skin health and diseaseDiffuse plate-like sheets of desquamation.
JAAD case reportsAnalysis of TYR Gene Pathogenic Variants in a Chinese Mongolian Family with Progressive Symmetric Erythrokeratoderma.
Indian dermatology online journalIchthyosis, psoriasiform dermatitis, and recurrent fungal infections in patients with biallelic mutations in PERP.
Journal of the European Academy of Dermatology and Venereology : JEADVProgressive hyperpigmented rash in a 10-year-old boy.
Pediatric dermatologyFormation of keto-type ceramides in palmoplantar keratoderma based on biallelic KDSR mutations in patients.
Human molecular geneticsCardiac features in a patient with erythrokeratodermia cardiomyopathy syndrome.
Cardiology in the youngProgressive symmetrical erythrokeratoderma manifesting as harlequin-like ichthyosis with severe thrombocytopenia secondary to a homozygous 3-ketodihydrosphingosine reductase mutation.
JAAD case reportsELOVL4 with erythrokeratoderma: A pediatric case and emerging genodermatosis.
American journal of medical genetics. Part ADermoscopy of Erythrokeratoderma Variabilis.
Indian dermatology online journalProgressive Deformity of the Lower Limbs in a Patient with KID (Keratitis-Ichthyosis-Deafness) Syndrome.
Case reports in orthopedicsFulminant myocarditis following recurrent generalized erythrokeratoderma in a child with a heterozygous GJA1 variant.
American journal of medical genetics. Part AClinical variability of the GJB4:c.35G > A gene variant: a study of a large Brazilian erythrokeratodermia pedigree.
International journal of dermatologyIdentification of a CDH12 potential candidate genetic variant for an autosomal dominant form of transgrediens and progrediens palmoplantar keratoderma in a Tunisian family.
Journal of human geneticsConfirming the recessive inheritance of PERP-related erythrokeratoderma.
Clinical geneticsLoricrin downregulation and epithelial-related disorders: a systematic review.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDGConnexin 43 Mutations Lead to Increased Hemichannel Functionality in Skin Disease.
International journal of molecular sciencesProgressive Symmetrical Erythrokeratoderma Associated with Punctate Palmoplantarkeratoderma.
Indian dermatology online journalChronic symmetrically distributed hyperpigmented plaques in a middle-age woman.
JAAD case reportsMutations in PERP Cause Dominant and Recessive Keratoderma.
The Journal of investigative dermatologyThe PERIOPTER syndrome (periorificial and ptychotropic erythrokeratoderma): a new Mendelian disorder of cornification.
Journal of the European Academy of Dermatology and Venereology : JEADVErythrokeratoderma: a manifestation associated with multiple types of ichthyoses with different gene defects.
The British journal of dermatologyBiallelic Mutations in KDSR Disrupt Ceramide Synthesis and Result in a Spectrum of Keratinization Disorders Associated with Thrombocytopenia.
The Journal of investigative dermatologyKeratitis-ichthyosis-deafness syndrome accompanied by disseminated cutaneous fungal infection.
The Journal of dermatologyMutations in KDSR Cause Recessive Progressive Symmetric Erythrokeratoderma.
American journal of human geneticsRecessive progressive symmetric erythrokeratoderma results from a homozygous loss-of-function mutation of KRT83 and is allelic with dominant monilethrix.
Journal of medical geneticsLate Onset Progressive Symmetric Erythrokeratoderma with Pseudo Ainhum.
Indian journal of dermatologyLethal Keratitis, Ichthyosis, and Deafness Syndrome Due to the A88V Connexin 26 Mutation.
Revista de investigacion clinica; organo del Hospital de Enfermedades de la NutricionProgressive symmetrical erythrokeratoderma on the face: A rare condition and successful treatment with calcipotriol.
JAAD case reportsPhenotype in a patient with p.D50N mutation in GJB2 gene resemble both KID and Clouston syndromes.
International journal of pediatric otorhinolaryngologyHerpes simplex virus in erythrokeratoderma variabilis.
Dermatology online journalErythrokeratoderma Variabilis Caused by p.Gly45Glu in Connexin 31: Importance of the First Extracellular Loop Glycine Residue for Gap Junction Function.
Acta dermato-venereologicaIntrafamilial phenotypic heterogeneity of epidermolytic ichthyosis associated with a new missense mutation in keratin 10.
Clinical and experimental dermatologyProgressive Symmetric Erythrokeratoderma Having Overlapping Features With Erythrokeratoderma Variabilis and Lesional Hypertrichosis: Is Nomenclature "Erythrokeratoderma Variabilis Progressiva" More Appropriate?
Indian journal of dermatologyPhenotypic variability in gap junction syndromic skin disorders: experience from KID and Clouston syndromes' clinical diagnostics.
Journal of applied geneticsAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Eritroceratodermia.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Eritroceratodermia
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Progressive symmetrical erythrokeratoderma associated with biallelic PNPLA1 variants.
- A recurrent de novo damaging variant in EMP2 causes progressive symmetric erythrokeratoderma.Proceedings of the National Academy of Sciences of the United States of America· 2025· PMID 40758889mais citado
- Progressive Symmetric Erythrokeratoderma with Lesional Hypertrichosis: An Unusual Finding in a Rare Disease.
- Topical Treatments for Rare Genetic Dermatological Diseases: A Narrative Review.
- Erythrokeratodermia-Cardiomyopathy Syndrome: Expanding the DSP Mutational Spectrum Beyond Proline Substitutions.
- Progressive Symmetric Erythrokeratoderma in an Adolescent With a Novel GJB3 Variant.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:79355(Orphanet)
- MONDO:0019270(MONDO)
- GARD:18986(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Q5396475(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
